No Detail Found!

Outcomes of Hepatitis E in Pregnancy

Author(s)
IRAM INAM Department of Gynae/Obs, Continental Medical College Lahore, Pakistan
GHIAS UL HASSAN Department of Gastroenterology, PGMI/LGH Lahore,Pakistan
SABOOHI SAEED Department Physiology, Azra Naheed Medical & Dental College Lahore,Pakistan
SAADIA SAJJAD Department Physiology, Abu Ammara Medical & Dental College Lahore,Pakistan
SAIMA SHEIKH Department Physiology, Khawaja Safdar Medical College Sialkot,Pakistan
Abstract
Hepatitis E virus infection is an emerging challenge of the developing world. During pregnancy, hepatitis E Virus results in devastating effects endangering the life of both mother and fetus. Hepatitis E contribute to 19% to 25% of maternal and 7-13% of all neonatal deaths. Purpose of this study is to see the association between hepatitis E virus infection and fetomaternal outcomes in pregnancy. Material & Methods: A prospective study design was used. Study was conducted in a tertiary health care sector for a period of March 2018 to January 2021 with sample size of 60 pregnant women. Study was conducted after getting institutional approval and informed consent was taken from all the study participants. Ethical considerations were followed throughout the study period. Data was analyzed using SPSS version 23.0 and descriptive statistics was used. Results: Out of 60 pregnancies, 19 (30%) suffered with PPH, 14 (23.33%) had history of DIC and 16 (26.66%) cases of hepatic encephalopathy were evident. Preterm SVD was a majority reason seen for ending the pregnancy. Results showed that hepatitis E virus caused multiple fetal morbidities. Conclusion: High mortality rate was evident in hepatitis E virus infection affected pregnancies in this study. There is a need to educate pregnant ladies regarding preventive measures to avoid fulminant consequences. Emphasis should be given to follow hygienic practices during pregnancy and proper antenatal visits are mandatory to educate the women.
Publication Details
Page(s) 234-236
Published Journal: Pakistan Journal of Medical and Health Sciences, Volume: 16, Issue: 05, Year: 2022

Request the full text from PASTIC

Keywords
pregnancy, Hepatitis E, Fetus Outcomes, Maternal.
References
Bergløv A,Hallager S,Weis N. . .Hepatitis E during pregnancy: maternal and foetal case‐fatality rates and adverse outcomes-a systematic review. 2019 Nov, 26(11) : 1240-8.
Bigna JJ,Modiyinji AF,Nansseu JR,Amougou MA,Nola M,Kenmoe S,Temfack E,Njouom R . .Burden of hepatitis E virus infection in pregnancy and maternofoetal outcomes: a systematic review and meta-analysis. BMC pregnancy and childbirth, 20(1) : 1-1.
Yasmeen T,Hashmi HA,Taj A . .Fetomaternal outcome with hepatitis e in pregnancy. 2013 Oct, 1(10) : 711-4.
Kumar A,Devi SG,Kar P,Agarwal S,Husain SA,Gupta RK,Sharma S. . .Association of cytokines in hepatitis E with pregnancy outcome. , : .
Cytokine . .. 2014 Jan, 1(1) : 95-104.
Shinde NR,Patil TB,Deshpande AS,Gulhane RV,Patil MB,Bansod YV. . .Clinical profile, maternal and fetal outcomes of acute hepatitis e in pregnancy. Annals of medical and health sciences research., : .
Bose PD,Das BC,Kumar A,Gondal R,Kumar D,Kar P . .High viral load and deregulation of the progesterone receptor signaling pathway: association with hepatitis E-related poor pregnancy outcome. 2011 Jun, 1(6) : 1107-13.
Kar P,Sengupta A . .A guide to the management of hepatitis E infection during pregnancy. Expert Review of Gastroenterology & Hepatology. 2019 Mar, 4(3) : 205-11.
Aslan AT,Balaban HY . .Hepatitis E virus: Epidemiology, diagnosis, clinical manifestations, and treatment. 2020 Oct, 7(37) : 5543.
Microbiology Newsletter Clinical . .. 2020 Nov, 1(21) : 171-9.
Obiri-Yeboah D,Asante Awuku Y,Adu J,Pappoe F,Obboh E,Nsiah P,Amoako-Sakyi D,Simpore J . .Sero-prevalence and risk factors for hepatitis E virus infection among pregnant women in the Cape Coast Metropolis, Ghana. 2018 Jan, 25(1) : e0191685.
Lhomme S,Marion O,Abravanel F,Izopet J,Kamar N. . .Clinical manifestations, pathogenesis and treatment of hepatitis E virus infections. 2020 Feb;9, (2) : 331.
Karna R,Hazam RK,Borkakoti J,Kumar A,Kar P. . .A 5-year singlecenter experience of hepatitis E virus infection during pregnancy. , : .
. .. 2020 Mar, 1(2) : 135-8.
Goel A,Aggarwal R. Hepatitis A . .E: epidemiology, clinical course, prevention, and treatment. 2020 Jun, 1(2) : 315-30.
Cheung CK,Wong SH,Law AW,Law MF . .Transfusion-transmitted hepatitis E: What we know so far?. 2022 Jan, 7(1) : 47.
Ahmad T,Hui J,Musa TH,Behzadifar M,Baig M. . .Seroprevalence of hepatitis E virus infection in pregnant women: a systematic review and meta-analysis. 2020 Mar;40, (2) : 136-46.
Zaman K,Dudman S,Stene-Johansen K,Qadri F,Yunus M,Sandbu S,Gurley ES,Overbo J,Julin CH,Dembinski JL,Nahar Q. . .HEV study protocol: design of a cluster-randomised, blinded trial to assess the safety, immunogenicity and effectiveness of the hepatitis E vaccine HEV 239 (Hecolin) in women of childbearing age in rural Bangladesh. 2020 Jan, 1(1) : e033702.
Aggarwal R,Goel A . .Natural history, clinical manifestations, and pathogenesis of hepatitis E virus genotype 1 and 2 infections. 2019 Jul, 1(7) : a032136.
Khan SA,Khan Z,Alam Z,Sana H,Ali M,Zaman N,Ualiveya D,Rizwan M,Suleman M. Hepatitis . .E virus sero-prevalence among pregnant women in Khyber Pakhtunkhwa Pakistan. Clinical Immunology Communications. 2022 Apr, 4 : .
Farshadpour F,Taherkhani R,Ravanbod MR,Eghbali SS,Taherkhani S,Mahdavi E.,Prevalence E. . .risk factors and molecular evaluation of hepatitis E virus infection among pregnant women resident in the northern shores of Persian Gulf, Iran. 2018 Jan, 12(1) : e0191090.
0

Citations

0

Downloads

95

Views